Delivery Order SPE2DB24D2101-SPE2DB25FKMWL
- Not listed
- The Defense Logistics Agency awarded a $23,920.84 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania by August 18, 2025. This competitive award, issued under a firm fixed-price delivery order contract with no set-aside designation, represents a single transaction on AmerisourceBergen's larger pharmaceutical supply agreement with the agency. This delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $198,735.12 firm fixed price delivery order contract to AmerisourceBergen Drug Corp. This contract is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The award has an ultimate completion date of August 19, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which AmerisourceBergen holds with the...
- The Defense Logistics Agency awarded a delivery order valued at $71,762.52 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product for military healthcare systems. This firm fixed-price delivery order, awarded on July 28, 2025, carries an ultimate completion date of August 18, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This firm fixed price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 20, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary operational hub for federal...
- The Defense Logistics Agency awarded a $59,802.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The delivery order, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, represents a non-set-aside competitive award to the prime contractor. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a $107,355.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product, with a performance period through January 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This firm fixed-price delivery order, valued at $59,802.10, was awarded on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract represents a non-set-aside award issued under competitive procurement, reflecting...
- This is a $45,689.76 delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) on December 13, 2024. The order is for the supply of 4,566,716,735 units of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies to...
- The Defense Logistics Agency awarded a $107,643.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product, with an ultimate completion date of August 22, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery location is AmerisourceBergen's...
- This delivery order, valued at $191,366.72, was awarded on July 23, 2025, to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products. The contract is non-set-aside and firm fixed price in nature, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this award. The contract is funded through the Medical Supply Chain division of the Department...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMWLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies valued at $23,920.84 on July 29, 2025, with completion expected by August 19, 2025. The delivery order is for DARZALEX FASPRO 1,800mg-30,000 15ml units, a specialty medication used in hematologic malignancy treatment. This contract employs firm fixed price terms with no set-aside designation, indicating competitive award based on open competition. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications and medical commodities to support military healthcare systems worldwide. AmerisourceBergen maintains a significant federal presence as a major pharmaceutical distributor, regularly fulfilling DLA requirements across multiple therapeutic domains for military and veteran healthcare needs. The company's competitively awarded federal contract portfolio demonstrates its capability to meet stringent federal procurement standards for specialized pharmaceutical products and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.9k | 7/29/25 |